HAL (France)open access
Optimizing nanobody-based molecules targeting mesothelin: Exploring format, valency, size, and half-life for next-generation cancer theranostics
Mesothelin, Tumor targeting, Cancer imaging, Nanobody-based engineering, 0, 1, 2, Nanobodies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 330076
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.